Generis’ Post

CDER’s recent research takes the Spotlight! 🌟 Check out the latest Spotlight on CDER Science, which highlights research that examined the safety aspects of switching between reference #biologics and #biosimilars: https://lnkd.in/d2s2EtHU

20 year's experience has generated strong scientific support for interchangeability of biosimilars approved according to standards set by major regulatory authorities such as #FDA and #ema. This statement from US-FDA is fully aligned with our statement from April 2023 (https://lnkd.in/d9Fkqmk5) underpinning that biosimilars offers an alternative that are equally safe and effective as their reference counterparts

CDER’s recent research takes the Spotlight! 🌟 Check out the latest Spotlight on CDER Science, which highlights research that examined the safety aspects of switching between reference #biologics and #biosimilars: https://lnkd.in/d2s2EtHU

2024 has started and there are many biosimilars being covered that may not have been covered before on your formulary- if you have worried about switching between a biosimilar and the reference product, then check out this article that highlights research conducted by FDA staff. The bottom line: In the meta-analyses, the researchers found zero difference in the risk of death, serious adverse events, and treatment discontinuations between participants who switched between biosimilars and reference products and participants who did not switch.

Meet our leadership team to discuss how Syngene can accelerate your drug development needs

It is the first day of #Biologics 2024! We are excited to learn more about biologics and how AI can be integrated into the discovery workflow to predict structures, developability and affinity - ultimately improving lead optimization Oxford Global

Achieving consistent production of biological therapeutics presents distinctive challenges in bioanalysis. Find out how we addressed these challenges and ensured superior sensitivity in this poster presentation: https://lnkd.in/gH98pK5a #DrugDevelopment #Biologics #LifeSciences

The BIOlympics have begun... Who will claim the gold medal in innovation? This competition isn’t just about speed, or is it?! 🤔 Scroll down to witness the thrilling race. Want to stay ahead? Explore the BIOlympics and see how FairJourney Biologics is securing your victory with strategic foresight and full validated lead: https://lnkd.in/g2vvZTmj #olympics #antibody #olympicgames #biologics

🚨 Last chance to meet David Muñoz at Swiss Biotech Day! 🚨 Today's the final day of the conference, and we are eager to connect with you. Don't miss out on the opportunity to discuss biotech innovations and potential collaborations. 📧 Send directly a message to David Muñoz to schedule a meeting. See you there! #Biotech #CDMO #SwissBiotechDay #Biopharmaceuticals #Biologics #3PBIOVIAN Swiss Biotech Association

Will you be in San Diego for #BIO2024? If so, don't forget to visit Curia on booth 4607. Our experts will be on booth to answer your pressing #smallmolecules and #biologics drug development queries and share best practices honed across more than 30 years of experience! #cdmo #drugdiscovery #biotechnology #sterilefillfinish #drugsubstance #drugproduct #api